-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F+d+v2TWDYjoToXL8nQZiSGjtI6tBa++82SPbGywUJUBbz+mxGL1KzkIoOtb9BxU rSaLnmgLK9gz4d43fSNtHg== 0001179110-06-012641.txt : 20060605 0001179110-06-012641.hdr.sgml : 20060605 20060605134529 ACCESSION NUMBER: 0001179110-06-012641 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060601 FILED AS OF DATE: 20060605 DATE AS OF CHANGE: 20060605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KUNG ROBERT T V CENTRAL INDEX KEY: 0001203037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 06885614 MAIL ADDRESS: STREET 1: C/O ABIOMED INC STREET 2: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 4 1 edgar.xml FORM 4 - X0202 4 2006-06-01 0 0000815094 ABIOMED INC ABMD 0001203037 KUNG ROBERT T V C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS MA 01923 0 1 0 0 SVP, Chief Scientific Officer Common Stock, $.01 par value 87060 I By Trust Common Stock, $.01 par value 16968 I By Trust Common Stock, $.01 par value 100200 I By Trust Stock Option (right to buy) 6.813 2003-07-01 2008-07-01 Common Stock 40000 40000 D Stock Option (right to buy) 6.688 2001-07-01 2009-07-01 Common Stock 20000 20000 D Stock Option (right to buy) 15.563 2002-06-28 2010-06-28 Common Stock 40000 40000 D Stock Option (right to buy) 24.12 2003-06-22 2011-06-22 Common Stock 20000 20000 D Stock Option (right to buy) 6.75 2004-06-25 2012-06-25 Common Stock 50000 50000 D Stock Option (right to buy) 5.11 2005-06-25 2013-06-25 Common Stock 16000 16000 D Stock Option (right to buy) 12.300 2005-07-01 2014-07-01 Common Stock 20000 20000 D Stock Option (right to buy) 9.360 2006-06-08 2015-06-08 Common Stock 20000 20000 D Stock Option (right to buy) 13.570 2006-06-01 4 A 0 20000 13.570 A 2007-06-01 2016-06-01 Common Stock 20000 20000 D Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1992 Combination Stock Option Plan. Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan. Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan. Options were fully exercisable on the date shown. Thirty percent of this option will become exercisable on each of 7/1/01 and 7/1/02 and an addtional 40 percent will become exercisable on 7/1/03 Thirty percent of this option will become exercisable on each of 6/28/02 and 6/28/03 and an addtional 40 percent will become exercisable on 6/28/04. Thirty percent of this option will become exercisable on each of 6/22/03 and 6/22/04 and an addtional 40 percent will become exercisable on 6/22/05. Thirty percent of this option will become exercisable on each of 6/25/04 and 6/25/05 and an addtional 40 percent will become exercisable on 6/25/06. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes. These shares are held in trust for the benefit of the reporting person's spouse. Thirty percent of this option will become exercisable on each of 6/25/05 and 6/25/06 and an addtional 40 percent will become exercisable on 6/25/07. These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. /s/ Charles B. Haaser (attorney-in-fact) 2006-06-05 -----END PRIVACY-ENHANCED MESSAGE-----